| Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors AGA El‐Helby, H Sakr, IH Eissa, H Abulkhair, AA Al‐Karmalawy, K El‐Adl Archiv der Pharmazie 352 (10), 1900113, 2019 | 119 | 2019 |
| Benzoxazole/benzothiazole‐derived VEGFR‐2 inhibitors: design, synthesis, molecular docking, and anticancer evaluations AGA El‐Helby, H Sakr, IH Eissa, AA Al‐Karmalawy, K El‐Adl Archiv Der Pharmazie 352 (12), 1900178, 2019 | 89 | 2019 |
| Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents MA El-Zahabi, H Sakr, K El-Adl, M Zayed, AS Abdelraheem, SI Eissa, ... Bioorganic chemistry 104, 104218, 2020 | 80 | 2020 |
| Design, synthesis, and anti-proliferative evaluation of new quinazolin-4 (3H)-ones as potential VEGFR-2 inhibitors K El-Adl, AGA El-Helby, RR Ayyad, HA Mahdy, MM Khalifa, HA Elnagar, ... Bioorganic & Medicinal Chemistry 29, 115872, 2021 | 74 | 2021 |
| Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme K El-Adl, AGA El-Helby, H Sakr, IH Eissa, SSA El-Hddad, FMIA Shoman Bioorganic chemistry 102, 104059, 2020 | 74 | 2020 |
| Discovery of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation IH Eissa, AGA El-Helby, HA Mahdy, MM Khalifa, HA Elnagar, ... Bioorganic Chemistry 105, 104380, 2020 | 69 | 2020 |
| Design, synthesis, molecular docking, and anticancer activity of phthalazine derivatives as VEGFR‐2 inhibitors AGA El‐Helby, RRA Ayyad, H Sakr, K El‐Adl, MM Ali, F Khedr Archiv der Pharmazie 350 (12), 1700240, 2017 | 63 | 2017 |
| Design, synthesis, molecular modeling and biological evaluation of novel 2, 3-dihydrophthalazine-1, 4-dione derivatives as potential anticonvulsant agents AGA El-Helby, RR Ayyad, HM Sakr, AS Abdelrahim, K El-Adl, FS Sherbiny, ... Journal of Molecular Structure 1130, 333-351, 2017 | 63 | 2017 |
| Discovery of new quinoxaline-2 (1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation K El-Adl, HM Sakr, RG Yousef, ABM Mehany, AM Metwaly, ... Bioorganic Chemistry 114, 105105, 2021 | 62 | 2021 |
| New quinoxaline-2 (1 H)-ones as potential VEGFR-2 inhibitors: Design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations RG Yousef, HM Sakr, IH Eissa, ABM Mehany, AM Metwaly, ... New Journal of Chemistry 45 (36), 16949-16964, 2021 | 61 | 2021 |
| [1, 2, 4] Triazolo [4, 3-c] quinazoline and bis ([1, 2, 4] triazolo)[4, 3-a: 4′, 3′-c] quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile … K El-Adl, MK Ibrahim, MSI Alesawy, IH Eissa Bioorganic & Medicinal Chemistry 30, 115958, 2021 | 55 | 2021 |
| Design, synthesis, molecular docking and anticonvulsant evaluation of novel 6-iodo-2-phenyl-3-substituted-quinazolin-4 (3H)-ones MK Ibrahim, K El-Adl, AA Al-Karmalawy Bulletin of Faculty of Pharmacy, Cairo University 53 (2), 101-116, 2015 | 50 | 2015 |
| Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors NM Saleh, MSA El-Gaby, K El‐Adl, NEA Abd El-Sattar Bioorganic Chemistry 104, 104350, 2020 | 49 | 2020 |
| Design, synthesis, in silico ADMET profile and GABA‐A docking of novel phthalazines as potent anticonvulsants AGA El‐Helby, RRA Ayyad, MF Zayed, HS Abulkhair, H Elkady, K El‐Adl Archiv Der Pharmazie 352 (5), 1800387, 2019 | 49 | 2019 |
| Design and synthesis of some novel 2-(3-methyl-2-oxoquinoxalin-1 (2H)-yl)-N-(4-(substituted) phenyl) acetamide derivatives for biological evaluation as anticonvulsant agents MK Ibrahim, AA Abd-Elrahman, RRA Ayyad, K El-Adl, AM Mansour, ... Bulletin of Faculty of Pharmacy, Cairo University 51 (1), 101-111, 2013 | 49 | 2013 |
| The antimicrobial potential and pharmacokinetic profiles of novel quinoline-based scaffolds: synthesis and in silico mechanistic studies as dual DNA gyrase and DHFR inhibitors MH El-Shershaby, KM El-Gamal, AH Bayoumi, K El-Adl, M Alswah, ... New Journal of Chemistry 45 (31), 13986-14004, 2021 | 48 | 2021 |
| Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2, 4‐dichloro) benzylidene] thiazolidine‐2, 4‐dione … K El‐Adl, AGA El‐Helby, H Sakr, RR Ayyad, HA Mahdy, M Nasser, ... Archiv der Pharmazie 354 (2), 2000279, 2021 | 47 | 2021 |
| Design, synthesis, molecular docking and anti-proliferative evaluations of [1, 2, 4] triazolo [4, 3-a] quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors K El-Adl, AGA El-Helby, H Sakr, A Elwan Bioorganic Chemistry 105, 104399, 2020 | 47 | 2020 |
| Phthalazine-1, 4-dione derivatives as non-competitive AMPA receptor antagonists: design, synthesis, anticonvulsant evaluation, ADMET profile and molecular docking AGA El-Helby, RRA Ayyad, K El-Adl, H Elkady Molecular diversity 23, 283-298, 2019 | 47 | 2019 |
| Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies A Turky, AH Bayoumi, FF Sherbiny, K El-Adl, HS Abulkhair Molecular diversity 25, 403-420, 2021 | 45 | 2021 |
